Go Pro

Mineralys Therapeutics (MLYS) Institutional Ownership

Mineralys Therapeutics logo
$25.64 -0.45 (-1.72%)
Closing price 04:00 PM Eastern
Extended Trading
$25.66 +0.02 (+0.06%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Mineralys Therapeutics (NASDAQ:MLYS)

Current
Institutional Ownership
Percentage
84.46%
Number of
Institutional Buyers
(last 12 months)
142
Total
Institutional Inflows
(last 12 months)
$1.26B
Number of
Institutional Sellers
(last 12 months)
55
Total
Institutional Outflows
(last 12 months)
$456.38M
Get MLYS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MLYS Institutional Buying and Selling by Quarter

Mineralys Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026Parkman Healthcare Partners LLC380,354$10.26M1.1%N/A0.430%
8/14/2026Legal & General Group Plc38,050$1.03M0.0%N/A0.043%
8/14/2026The Manufacturers Life Insurance Company 32,007$864K0.0%N/A0.036%
8/14/2026Algert Global LLC649,027$17.51M0.2%+149.4%0.734%
8/12/2026 Greenland Capital Management LP30,000$809K0.1%N/A0.036%
8/11/2026 E Fund Management Co. Ltd.11,025$297K0.0%N/A0.013%
8/8/2026 Timothy G. Youngquist 2020 Irrevocable Trust100,869$2.72M0.5%N/A0.122%
8/7/2026 BlackRock Inc.5,887,038$158.83M0.0%N/A7.136%
8/7/2026 Deutsche Bank AG58,877$1.59M0.0%N/A0.071%
8/7/2026 TimesSquare Capital Management LLC235,858$6.36M0.1%N/A0.286%
8/7/2026 Persistent Asset Partners Ltd14,410$389K0.1%N/A0.017%
8/6/2026 Bank of New York Mellon Corp158,550$4.28M0.0%N/A0.192%
8/3/2026 Walleye Capital LLC10,052$271K0.0%N/A0.012%
7/10/2026 Handelsbanken Fonder AB27,200$734K0.0%+92.9%0.033%
7/9/2026 Hennion & Walsh Asset Management Inc.69,580$1.88M0.1%-0.9%0.084%
7/8/2026 FNY Investment Advisers LLC2,500$67K0.0%+400.0%0.003%
6/4/2026Seven Fleet Capital Management LP69,571$1.89M0.6%+65.5%0.084%
5/19/2026Bank of America Corp DE1,100,372$29.81M0.0%+11.5%1.334%
5/19/2026Stempoint Capital LP533,378$14.45M2.8%+83.9%0.647%
5/19/2026Janus Henderson Group PLC19,848$537K0.0%-98.4%0.024%
5/18/2026ADAR1 Capital Management LLC154,686$4.19M0.2%+13.5%0.187%
5/18/2026California State Teachers Retirement System61,266$1.66M0.0%+41.3%0.074%
5/18/2026Rock Springs Capital Management LP439,751$11.91M0.7%+2.8%0.533%
5/16/2026The Manufacturers Life Insurance Company26,411$715K0.0%+63.2%0.032%
5/16/2026Quantinno Capital Management LP20,541$556K0.0%+12.6%0.025%
5/16/2026Orbimed Advisors LLC2,052,900$55.61M1.0%+109.4%2.488%
5/15/2026Troluce Capital Advisors LLC655,000$17.74M1.1%N/A0.794%
5/15/2026Affinity Asset Advisors LLC750,000$20.32M1.0%+2.7%0.909%
5/15/2026Entropy Technologies LP10,180$276K0.0%-37.1%0.012%
5/14/2026Renaissance Technologies LLC382,800$10.37M0.0%+18.8%0.464%
5/14/2026Pale Fire Capital SE365,626$9.91M0.8%+3,431.3%0.443%
5/14/2026Sei Investments Co.11,692$317K0.0%+33.2%0.014%
5/7/2026 KBC Group NV1,233$33K0.0%N/A0.001%
5/6/2026 Jennison Associates LLC1,266,174$34.30M0.0%+0.6%1.536%
5/5/2026 Bank of New York Mellon Corp129,964$3.52M0.0%-1.4%0.158%
5/1/2026Candriam S.C.A.801,904$21.72M0.1%+18.2%0.973%
4/29/2026 Swedbank AB122,100$3.31M0.0%-44.9%0.148%
4/27/2026 Y Intercept Hong Kong Ltd132,099$3.58M0.1%+321.2%0.160%
4/22/2026 Pictet Asset Management Holding SA1,034,438$28.02M0.0%+21.3%1.255%
4/16/2026 SG Americas Securities LLC225,833$6.12M0.0%-2.1%0.274%
Barricks gold output fell from 2 million ounces to 719000 (Ad)

Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-largest miner running on fumes. Newmont's $15 billion purchase of Newcrest, the largest mining deal in history, still couldn't keep output growing, proof that majors must keep buying to survive. With record cash flows and shrinking mines, gold majors are positioned to launch a wave of acquisitions targeting the best junior assets.tc pixel

See the top three gold buyout targets to watch now
3/3/2026 Caitong International Asset Management Co. Ltd3,823$139K0.0%+3,439.8%0.005%
2/26/2026Seven Fleet Capital Management LP15,243$553K0.4%N/A0.019%
2/19/2026Invesco Ltd.29,141$1.06M0.0%-84.5%0.037%
2/18/2026XTX Topco Ltd73,678$2.67M0.1%+291.1%0.093%
2/18/2026Zimmer Partners LP57,500$2.09M0.1%-42.5%0.073%
2/18/2026Ikarian Capital LLC200,000$7.26M0.6%N/A0.253%
2/18/2026 Virtus Investment Advisers LLC7,209$262K0.1%-5.5%0.009%
2/18/2026Wellington Management Group LLP784,267$28.46M0.0%+0.1%0.991%
2/18/2026Sphera Funds Management LTD.449,003$16.29M3.1%+104.2%0.567%
2/18/2026Suvretta Capital Management LLC1,538,662$55.84M1.1%-27.8%1.944%
2/18/2026Orbimed Advisors LLC980,400$35.58M0.8%-33.3%1.239%
2/18/2026Moore Capital Management LP60,000$2.18M0.0%-63.6%0.076%
2/18/2026Janus Henderson Group PLC1,213,265$44.01M0.0%+6,012.8%1.533%
2/18/2026Findell Capital Management LLC50,000$1.81M0.5%-80.0%0.063%
2/18/2026Catalio Capital Management LP331,849$12.04M2.2%N/A0.419%
2/18/2026Cinctive Capital Management LP7,037$255K0.0%-90.2%0.009%
2/18/2026Artia Global Partners LP137,800$5.00M0.7%+143.5%0.174%
2/18/2026Armistice Capital LLC676,035$24.53M0.3%+33.2%0.854%
2/17/2026ADAR1 Capital Management LLC136,231$4.94M0.4%+74.1%0.172%
2/17/2026Schonfeld Strategic Advisors LLC49,821$1.81M0.0%+240.8%0.063%
2/17/2026AQR Capital Management LLC62,300$2.26M0.0%+243.8%0.079%
2/17/2026Trexquant Investment LP112,788$4.09M0.0%+156.5%0.143%
2/17/2026Laurion Capital Management LP1,713,485$62.18M2.3%-0.4%2.165%
2/17/2026Farallon Capital Management LLC823,296$29.88M0.1%-50.8%1.040%
2/17/2026Iron Triangle Partners LP257,085$9.33M1.1%N/A0.325%
2/17/2026Price T Rowe Associates Inc. MD1,325,120$48.09M0.0%+6,097.1%1.674%
2/17/2026Rock Springs Capital Management LP427,596$15.52M0.8%+4.7%0.540%
2/17/2026California State Teachers Retirement System43,348$1.57M0.0%+18.4%0.055%
2/17/2026Diadema Partners LP25,000$907K0.2%N/A0.032%
2/17/2026 Russell Investments Group Ltd.175,361$6.36M0.0%+5,272.6%0.222%
2/17/2026Atom Investors LP22,330$810K0.1%N/A0.028%
2/17/2026State of Wisconsin Investment Board49,941$1.81M0.0%+85.5%0.063%
2/17/2026Royal Bank of Canada1,529$56K0.0%+262.3%0.002%
2/17/2026 Persistent Asset Partners Ltd7,416$269K0.1%N/A0.009%
2/17/2026Polar Capital Holdings Plc1,401,141$50.85M0.2%+32.3%1.770%
2/16/2026Squarepoint Ops LLC246,804$8.96M0.0%+473.8%0.312%
2/16/2026Mariner LLC10,230$371K0.0%-37.7%0.013%
2/16/2026Maven Securities LTD20,000$726K0.0%N/A0.025%
2/16/2026Entropy Technologies LP16,175$587K0.0%N/A0.020%
2/16/2026Barclays PLC223,283$8.10M0.0%-65.8%0.282%
2/13/2026Nantahala Capital Management LLC113,285$4.11M0.1%-28.6%0.143%
2/13/2026FORA Capital LLC11,050$401K0.0%+74.7%0.014%
2/13/2026Marshall Wace LLP249,130$9.04M0.0%N/A0.315%
2/13/2026The Manufacturers Life Insurance Company 16,181$587K0.0%+9.6%0.020%
2/13/2026Affinity Asset Advisors LLC730,000$26.49M1.5%-2.7%0.922%
2/13/2026Schroder Investment Management Group130,592$4.64M0.0%N/A0.165%
2/13/2026Rafferty Asset Management LLC127,917$4.64M0.0%+303.7%0.162%
2/13/2026Davern Capital Partners LP210,648$7.64M2.5%N/A0.266%
2/13/2026Velan Capital Investment Management LP151,000$5.48M3.2%-14.0%0.191%
2/13/2026Siren L.L.C.699,999$25.40M0.8%N/A0.885%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
2/13/2026Charles Schwab Investment Management Inc.461,300$16.74M0.0%+12.7%0.583%
2/13/2026 Police & Firemen s Retirement System of New Jersey12,683$460K0.0%+15.7%0.016%
2/13/2026 State Street Corp3,184,999$115.58M0.0%+144.4%4.025%
2/13/2026 Caitong International Asset Management Co. Ltd2,101$76K0.2%+1,845.4%0.003%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC75,897$2.75M0.0%+28.5%0.096%
2/13/2026Wells Fargo & Company MN56,756$2.06M0.0%+88.8%0.072%
2/13/2026Lord Abbett & CO. LLC312,396$11.34M0.0%N/A0.395%
2/13/2026Rhenman & Partners Asset Management AB142,571$5.17M0.5%-13.6%0.180%
2/12/2026MetLife Investment Management LLC26,005$944K0.0%+14.5%0.033%
2/12/2026 SR One Capital Management LP1,563,966$56.76M8.0%-26.0%1.976%


MLYS Institutional Ownership - Frequently Asked Questions

During the previous two years, 191 institutional investors and hedge funds held shares of Mineralys Therapeutics. The most heavily invested institutionals were Catalys Pacific LLC ($286.83M), RA Capital Management L.P. ($277.72M), BlackRock Inc. ($158.83M), Vanguard Group Inc. ($121.68M), State Street Corp ($115.58M), Caligan Partners LP ($105.14M), and Franklin Resources Inc. ($64.91M).Learn more on Mineralys Therapeutics' institutional investors.

84.46% of Mineralys Therapeutics' stock is owned by institutional investors. Learn more on MLYS's institutional investor holdings.

Of the 175 institutional investors that purchased Mineralys Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($5.89M), Orbimed Advisors LLC ($2.54M), RA Capital Management L.P. ($2.47M), Jennison Associates LLC ($2.19M), State Street Corp ($1.90M), Vanguard Group Inc. ($1.70M), and Farallon Capital Management LLC ($1.67M).

Institutional investors have bought a total of 36,879,665 shares in the last 24 months. This purchase volume represents approximately $1.26B in transactions.

Of the 55 institutional investors that sold Mineralys Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Capital International Investors ($1.74M), SR One Capital Management LP ($1.56M), Integral Health Asset Management LLC ($1.20M), Janus Henderson Group PLC ($1.19M), Catalys Pacific LLC ($1M), Farallon Capital Management LLC ($849.76K), and Suvretta Capital Management LLC ($593.47K).

Institutional investors have sold a total of 12,810,659 shares in the last 24 months. This volume of shares sold represents approximately $456.38M in transactions.



Institutional ownership data for NASDAQ:MLYS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners